Ikris Pharma Network Launches Digital Platform for Named Patient Program
Named Patient Program brings medicine requests, regulatory documentation, and shipment tracking into a single platform for healthcare professionals and eligible patients to simplify global access to specialty medicines NOIDA, India — September 9, 2026 — Ikris Pharma Network today announced the launch of Named Patient Program, a digital platform designed to simplify regulatory-compliant access to…
Submitpressreleaseindia
Ikris Pharma Network Announces the Availability of Triokris™ (Trientine Dihydrochloride) to Support Patients Living With Wilson’s Disease
Noida, India — 15 January, 2026 – Ikris Pharma Network announced the availability of Triokris™ (Trientine Dihydrochloride 250 mg Capsules), a therapeutic option for patients diagnosed with Wilson’s Disease, a rare inherited disorder of copper metabolism. Triokris is designed to support clinicians in the management of patients requiring chelation therapy, especially in cases where first-line…